...
机译:everolimus与索拉非尼的经济评价治疗转移性肾细胞一线舒尼替癌后失败
Analytica International, 24 West 40th Street, New York, NY 10018, United States;
University Frederico II of Napoli, Naples, Italy;
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United StatesUniversity of Washington, Seattle, WA, United States;
Certican; sorafenib; metastatic kidney cancerCost EffectivenessTNFSF15 protein, humanMarkov modelsEconomic EvaluationsunitinibQuality-Adjusted Life Years;
机译:Economic evaluation of sunitinib versus pazopanib and best supportive care for the treatment of metastatic renal cell carcinoma in Chile: cost-effectiveness analysis and a mixed treatment comparison
机译:Pazopanib or Sunitinib? cost-utility analysis of pazopanib versus sunitinib in the first-line treatment of metastatic renal cell carcinoma in Jordan
机译:Evaluation of relative dose intensity during the early phase of first-line sunitinib treatment using a 2-week-on/1-week-off regimen for metastatic renal cell carcinoma
机译:metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinib